159 related articles for article (PubMed ID: 9216855)
1. Loss of the tumor suppressor p53 gene at the liver cirrhosis stage in Japanese patients with hepatocellular carcinoma.
Kishimoto Y; Shiota G; Kamisaki Y; Wada K; Nakamoto K; Yamawaki M; Kotani M; Itoh T; Kawasaki H
Oncology; 1997; 54(4):304-10. PubMed ID: 9216855
[TBL] [Abstract][Full Text] [Related]
2. Frequent loss in chromosome 8p loci in liver cirrhosis accompanying hepatocellular carcinoma.
Kishimoto Y; Shiota G; Wada K; Kitano M; Nakamoto K; Kamisaki Y; Suou T; Itoh T; Kawasaki H
J Cancer Res Clin Oncol; 1996; 122(10):585-9. PubMed ID: 8879255
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity of the retinoblastoma gene in liver cirrhosis accompanying hepatocellular carcinoma.
Ashida K; Kishimoto Y; Nakamoto K; Wada K; Shiota G; Hirooka Y; Kamisaki Y; Itoh T; Kawasaki H
J Cancer Res Clin Oncol; 1997; 123(9):489-95. PubMed ID: 9341898
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity of the mannose 6-phosphate/insulin-like growth factor II receptor and p53 genes in human hepatocellular carcinoma.
Kishimoto Y; Morisawa T; Kitano M; Shiota G; Horie Y; Suou T; Ito H; Kawasaki H; Hasegawa J
Hepatol Res; 2001 May; 20(1):68-83. PubMed ID: 11282487
[TBL] [Abstract][Full Text] [Related]
5. Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma.
Piao Z; Kim H; Jeon BK; Lee WJ; Park C
Cancer; 1997 Sep; 80(5):865-72. PubMed ID: 9307185
[TBL] [Abstract][Full Text] [Related]
6. p53 expression in patients with cirrhosis with and without hepatocellular carcinoma.
Livni N; Eid A; Ilan Y; Rivkind A; Rosenmann E; Blendis LM; Shouval D; Galun E
Cancer; 1995 May; 75(10):2420-6. PubMed ID: 7736384
[TBL] [Abstract][Full Text] [Related]
7. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma.
Kondo Y; Kanai Y; Sakamoto M; Mizokami M; Ueda R; Hirohashi S
Hepatology; 2000 Nov; 32(5):970-9. PubMed ID: 11050047
[TBL] [Abstract][Full Text] [Related]
8. Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients.
Hsu HC; Peng SY; Lai PL; Sheu JC; Chen DS; Lin LI; Slagle BL; Butel JS
Cancer; 1994 Jan; 73(1):42-7. PubMed ID: 7506118
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinoma.
Aoki T; Miyamoto A; Marubashi S; Nagano H; Umeshita K; Fujiwara Y; Dono K; Nakamori S; Sakon M; Monden M
Int J Oncol; 2004 Feb; 24(2):441-6. PubMed ID: 14719122
[TBL] [Abstract][Full Text] [Related]
10. Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis.
Ding SF; Habib NA; Dooley J; Wood C; Bowles L; Delhanty JD
Br J Cancer; 1991 Dec; 64(6):1083-7. PubMed ID: 1684907
[TBL] [Abstract][Full Text] [Related]
11. [Study on loss of heterozygosity and microsatellite instability in hepatocellular carcinoma].
Cong WM; Zhang SH; Xian ZH; Wu WQ; Wu MC
Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):71-4. PubMed ID: 15842799
[TBL] [Abstract][Full Text] [Related]
12. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
[TBL] [Abstract][Full Text] [Related]
13. Allelic alterations in nontumorous liver tissues and corresponding hepatocellular carcinomas from chinese patients.
Ho MK; Lee JM; Chan CK; Ng IO
Hum Pathol; 2003 Jul; 34(7):699-705. PubMed ID: 12874766
[TBL] [Abstract][Full Text] [Related]
14. Aberrant DNA methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis.
Kanai Y; Ushijima S; Tsuda H; Sakamoto M; Hirohashi S
Cancer Lett; 2000 Jan; 148(1):73-80. PubMed ID: 10680595
[TBL] [Abstract][Full Text] [Related]
15. Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies.
Maggioni M; Coggi G; Cassani B; Bianchi P; Romagnoli S; Mandelli A; Borzio M; Colombo P; Roncalli M
Hepatology; 2000 Nov; 32(5):942-6. PubMed ID: 11050043
[TBL] [Abstract][Full Text] [Related]
16. [Loss of heterozygosity on chromosomes 17 and 16 in primary hepatocellular carcinomas].
Shao J; Li X; Liu Z
Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):428-30. PubMed ID: 11715437
[TBL] [Abstract][Full Text] [Related]
17. Genetic changes and histopathological grades in human hepatocellular carcinomas.
Konishi M; Kikuchi-Yanoshita R; Tanaka K; Sato C; Tsuruta K; Maeda Y; Koike M; Tanaka S; Nakamura Y; Hattori N
Jpn J Cancer Res; 1993 Aug; 84(8):893-9. PubMed ID: 8407553
[TBL] [Abstract][Full Text] [Related]
18. Fractional allelic loss in non-end-stage cirrhosis: correlations with hepatocellular carcinoma development during follow-up.
Roncalli M; Bianchi P; Grimaldi GC; Ricci D; Laghi L; Maggioni M; Opocher E; Borzio M; Coggi G
Hepatology; 2000 Apr; 31(4):846-50. PubMed ID: 10733538
[TBL] [Abstract][Full Text] [Related]
19. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas.
Ito T; Nishida N; Fukuda Y; Nishimura T; Komeda T; Nakao K
J Gastroenterol; 2004; 39(4):355-61. PubMed ID: 15168247
[TBL] [Abstract][Full Text] [Related]
20. Analysis of chromosomal instability in pulmonary or liver metastases and matched primary hepatocellular carcinoma after orthotopic liver transplantation.
Gross-Goupil M; Riou P; Emile JF; Saffroy R; Azoulay D; Lacherade I; Receveur A; Piatier-Tonneau D; Castaing D; Debuire B; Lemoine A
Int J Cancer; 2003 May; 104(6):745-51. PubMed ID: 12640682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
